The Synthgene Chlamydia Antigen Self-Test Kit is an in-vitro diagnostic device designed for the rapid, qualitative detection of Chlamydia trachomatis antigens. Intended for use with male urethral swabs or female cervical swabs, this test utilizes advanced immunochromatographic technology to deliver reliable results within 15–30 minutes, supporting timely clinical decision‑making and patient counseling.

Each kit includes all required components for specimen collection, extraction, and analysis. Following sample acquisition, the specimen is processed using the supplied reagents and applied to the test cassette. Result interpretation is straightforward:

• Positive: Two visible lines (Control + Test), indicating the presence of chlamydial antigen.
• Negative: One visible control line only, indicating no detectable antigen.

The test demonstrates high analytical sensitivity and specificity, making it a practical tool for point‑of‑care screening or preliminary evaluation prior to confirmatory laboratory testing. This is particularly important given the high prevalence of asymptomatic chlamydial infections and the need for early detection to prevent reproductive or urogenital complications.

Compact, secure, and easy to use, the kit is suitable for decentralized testing environments such as community clinics, outreach programs, telehealth-supported workflows, and pharmacy-based screening. While not a replacement for nucleic acid amplification testing (NAAT), it provides clinicians with a rapid, accessible method for initial assessment and patient triage.

The Synthgene Chlamydia Antigen Self-Test Kit delivers fast, dependable preliminary screening to support early identification and management of chlamydial infections.